This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 13 from Patent US 20060122119
General Information
DRACP ID DRACP01288
Peptide Name Sequence 13 from Patent US 20060122119
Sequence VPLDCVLYRY
Sequence Length 10
UniProt ID P40967 Q4WVN4 Q60696
PubChem CID Not available
Origin Homo sapiens
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C58H89N13O15S
Absent amino acids AEFGHIKMNQSTW
Common amino acids LVY
Mass 140120
Pl 6.15
Basic residues 1
Acidic residues 1
Hydrophobic residues 4
Net charge 0
Boman Index -472
Hydrophobicity 63
Aliphatic Index 136
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 2980
Absorbance 280nm 331.11
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2006/0122119 A1
Patent Title Peptides for use in antitumor immunotherapy.
Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002
Other Published ID CA2477762A1 EP1481009A2 WO2003074565A2 WO2003074565A3
This work is licensed under a Creative Commons Attribution 4.0 International License.